Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$359M |
| 2 |
Cloudflare
NET
|
+$345M |
| 3 |
Mercado Libre
MELI
|
+$330M |
| 4 |
Amazon
AMZN
|
+$254M |
| 5 |
Joby Aviation
JOBY
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$573M |
| 2 |
Booking.com
BKNG
|
+$473M |
| 3 |
Netflix
NFLX
|
+$376M |
| 4 |
AXON
Axon Enterprise
AXON
|
+$373M |
| 5 |
Spotify
SPOT
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 27.39% |
| 2 | Technology | 24.37% |
| 3 | Healthcare | 18.87% |
| 4 | Communication Services | 12.6% |
| 5 | Financials | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
JFrog
FROG
$10.1B
| $48.2M | 0.04% |
1,740,653
+12,742
| +0.7% | +$291K |
|
152
Coca-Cola
KO
$374B
| $48.1M | 0.04% |
798,693
+1,877
| +0.2% | +$117K |
|
153
Infosys
INFY
$50.1B
| $46.5M | 0.04% |
2,892,174
-248,196
| -8% | -$3.88M |
|
|
WNS
154
DELISTED
WNS Holdings
WNS
| $46M | 0.04% |
+624,221
| New | +$49.9M |
|
155
Teladoc Health
TDOC
$1.21B
| $45M | 0.04% |
1,776,578
-3,050,303
| -63% | -$76.8M |
|
156
Futu Holdings
FUTU
$14.7B
| $44.3M | 0.04% |
1,113,861
+32,843
| +3% | +$1.4M |
|
157
Aurora
AUR
$13.3B
| $43.9M | 0.04% |
14,930,461
| – | – |
|
158
Edwards Lifesciences
EW
$51.5B
| $43.8M | 0.04% |
464,040
-3,444
| -0.7% | -$299K |
|
159
BlackLine
BL
$1.74B
| $43.2M | 0.04% |
803,091
-206,998
| -20% | -$11.5M |
|
160
MP Materials
MP
$8.45B
| $43.2M | 0.04% |
1,886,613
+416,037
| +28% | +$9.54M |
|
161
Medtronic
MDT
$110B
| $42.2M | 0.04% |
478,445
+14,356
| +3% | +$1.24M |
|
162
Rexford Industrial Realty
REXR
$8.14B
| $41M | 0.03% |
785,855
+37,088
| +5% | +$2.02M |
|
163
Prologis
PLD
$132B
| $40M | 0.03% |
326,540
+17,373
| +6% | +$2.14M |
|
|
DADA
164
DELISTED
Dada Nexus
DADA
| $39.4M | 0.03% |
7,414,011
+314,871
| +4% | +$1.91M |
|
165
UnitedHealth
UNH
$367B
| $38.4M | 0.03% |
79,900
+79,827
| +109,352% | +$39M |
|
|
CYBR
166
DELISTED
CyberArk
CYBR
| $36.7M | 0.03% |
234,959
-10,821
| -4% | -$1.55M |
|
167
McDonald's
MCD
$196B
| $36.4M | 0.03% |
122,035
-2,142
| -2% | -$622K |
|
168
T. Rowe Price
TROW
$24.2B
| $36.1M | 0.03% |
322,522
+11,271
| +4% | +$1.23M |
|
169
Lufax Holding
LU
$1.29B
| $36M | 0.03% |
6,297,329
+10,518
| +0.2% | +$69.5K |
|
170
New York Times
NYT
$10.4B
| $33.1M | 0.03% |
841,273
+622,124
| +284% | +$23.7M |
|
|
JMIA
171
Jumia Technologies
JMIA
$705M
| $32M | 0.03% |
9,365,507
-4,401
| -0% | -$13.5K |
|
172
Fiverr
FVRR
$331M
| $30.5M | 0.03% |
1,172,737
+94,281
| +9% | +$2.84M |
|
|
EXAI
173
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $30.1M | 0.03% |
5,081,168
-160,912
| -3% | -$987K |
|
174
Ares Capital
ARCC
$14.1B
| $26.2M | 0.02% |
1,392,236
+74,029
| +6% | +$1.37M |
|
175
Twist Bioscience
TWST
$6.84B
| $26M | 0.02% |
1,269,926
+189,896
| +18% | +$2.84M |
|
Similar funds
Baillie Gifford & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Baillie Gifford & Co held 461 positions worth $118B, up 6.1% from $111B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Baillie Gifford & Co's Q2 2023 filing shows 7 new, 99 increased, 159 reduced and 164 closed positions. Its largest new stake was Yeti Holdings: 3,128,447 shares worth $122M. The largest sale was Tesla, an estimated $573M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- Baillie Gifford & Co's largest Q2 2023 buy was Yeti Holdings: 3,128,447 shares worth $122M.
- Baillie Gifford & Co added most to Datadog in Q2 2023, an estimated $359M increase.
- Baillie Gifford & Co's biggest Q2 2023 reduction was Tesla, cutting an estimated $573M.
- Baillie Gifford & Co fully exited RB Global in Q2 2023, selling an estimated $86.6M.
- Baillie Gifford & Co's ten largest holdings make up 41% of its $118B portfolio in Q2 2023.
- Baillie Gifford & Co opened 7 new positions and closed 164 in Q2 2023.
- Baillie Gifford & Co's portfolio value rose 6.1% quarter-over-quarter to $118B.
Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.